연구

연구업적

최근 5년 연구업적 현황
연도 2023년 2022년 2021년 2020년 2019년
SCI 논문
발표편수
책임 173편 163편 184편 135편 144편
공동 120편 115편 136편 168편 167편
합계 293편 278편 320편 303편 311편
2611. Outcomes of 5,000 pancreatectomies in Korean single referral center and literature reviews.
 Byun Y, Choi YJ, Han Y, Kang JS, Kim H, Kwon W, Jang JY.
J Hepatobiliary Pancreat Sci . 2021 Feb 26. Link
2610. Management Algorithms for Pancreatic Cystic Neoplasms: The Surgeon's Perspective.
 Kim HS, Jang JY.
Arch Pathol Lab Med . 2021 Jan 27. doi: 10.5858/arpa.2020-0395-RA Link
2609. Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer.
 Kang JS, Hong SY, Han Y. Sohn HJ, Lee M, Kang YH, Kim HS, Kim H, Kwon W, Jang JY.
Ann Surg Treat Res . 2021 Nov;101(5):266-273. doi: 10.4174/astr.2021.101.5.266. Link
2608. Comparison of perioperative short-term outcomes and oncologic long-term outcomes between open and laparoscopic distal pancreatectomy in patients with pancreatic ductal adenocarcinoma.
 Lee JM, Kim H, Kang JS, Byun Y, Choi YJ, Sohn HJ, Han Y, Kwon W, Jang JY.
Ann Surg Treat Res. 2021 Jun;100(6):320-328. Link
2607. Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX.
 Choi YJ, Byun Y, Kang JS, Kim HS, Han Y, Kim H, Kwon W, Oh DY, Paik WH, Lee SH, Ryu JK, Kim YT, Lee K, Kim H, Chie EK, Jang JY.
Gut Liver. 2021 May 15;15(3):466-475. Link
2606. Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Database: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).
 Kang JS, Mok L, Heo JS, Han IW, Shin SH, Yoon YS, Han HS, Hwang DW, Lee JH, Lee WJ, Park SJ, Park JS, Kim Y, Lee H, Yu YD, Yang JD, Lee SE, Park IY, Jeong CY, Roh Y, Kim SR, Moon JI, Lee SK, Kim HJ, Lee S, Kim H, Kwon W, Lim CS, Jang JY, Park T.
Gut Liver. 2021 May 7. doi: 10.5009/gnl20306. Link
2605. Diagnostic model for pancreatic cancer using multi-marker panel.
 Choi YJ, Yoon W, Lee A, Han Y, Byun Y, Kang JS, Kim H, Kwon W, Suh YA, Kim Y, Lee S, Namkung J, Han S, Choi Y, Heo JS, Park JO, Park JK, Kim SC, Kang CM, Lee WJ, Park T, Jang JY.
Ann Surg Treat Res . 2021 Mar;100(3):144-153. doi: 10.4174/astr.2021.100.3.144. Epub 2021 Feb 26. Link
2604. Development of theranostic dual-layered Au-liposome for effective tumor targeting and photothermal therapy
Miyeon Jeon, Gaeun Kim, Wooseung Lee, Seungki Baek, Han Na Jung & Hyung-Jun Im
Journal of Nanobiotechnology volume 19, Article number: 262 (2021) Link
2603. Updated Overall Survival of Ribociclib Plus Endocrine Therapy vs Endocrine Therapy Alone in Pre- and Perimenopausal Patients With HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Yen-Sen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K. Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi El-Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji and Debu Tripathy
Clinical cancer research 2021 Dec 29. Epub ahead of print Link
2602. A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer
Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-Un Woo, Miso Kim Se Hyun Kim Han Suk Ryu Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im
Cancer research and treatment 2021 Aug 13 Epub ahead of print Link